Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study - The Lancet Oncology
Descrição
Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study - The Lancet Oncology
Protein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancer
NHS Trial Analysis Finds That Grail's Galleri Clinical Laboratory Blood Test Can Detect 50 Cancers and Identify the Location of the Cancer - Dark Daily
ctDNA Tests for Early Cancer Detection - Are We There Yet?
The Lancet Oncology Publishes Results from SYMPLIFY, The First Prospective Study of a Multi-Cancer Early Detection Test in a Symptomatic Patient Population - GRAIL
Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study - The Lancet
Performance of the WID-qEC test versus sonography to detect uterine cancers in women with abnormal uterine bleeding (EPI-SURE): a prospective, consecutive observational cohort study in the UK - ScienceDirect
A spectroscopic liquid biopsy for the earlier detection of multiple cancer types
Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study - The Lancet
Brittany Bychkovsky, MD (@DrBBychkovsky) / X
Overdiagnosis in the population-based organized breast cancer screening program estimated by a non-homogeneous multi-state model: a cohort study using individual data with long-term follow-up, Breast Cancer Research
The presenting symptom signatures of incident cancer: evidence from the English 2018 National Cancer Diagnosis Audit
de
por adulto (o preço varia de acordo com o tamanho do grupo)
